Skip to main content
Equibles

ARGX · Argenx SE · Earnings Call Transcripts & Audio

Track ARGX — free

Use ARGX with AI

Add company filings, earnings and prices to ChatGPT or Claude, then ask questions in your own chat.

Choose your app for step-by-step connection instructions. Sign in with Equibles when asked; no code or API key is needed.

Claude ChatGPT

After connecting, ask your AI to use Equibles to research ARGX.

Other apps & server URL
https://mcp.equibles.com/mcp
Gemini CLI setup
or ask here

Free, nothing to set up — ALVIS runs on the same tools and cites every figure.

See what you can ask in ChatGPT or Claude

All connection guides →
$958.91 -11.75 (-1.21%) At close · Sep 30
Rebalance outlook locked
Market Cap
$60.40B
Shares
62.56M
Volume · Sep 30 243.7K Avg daily vol (3M) 283.45K

Argenx SE Earnings Call Transcripts

Quarterly earnings calls for Argenx SE (ARGX), with available speaker-labelled transcripts, captured audio replays, call highlights, 8-K earnings releases and periodic filings. Investor days and conferences appear here too.

Pull transcripts and briefs through the earnings call transcript API or MCP →
Conference
Investor event
2026-09-14
Argenx SE (ARGX) September 2026 Conference Transcript
No reported result — non-financial event
Audio Transcript Slides
Conference
Investor event
2026-09-08
Argenx SE (ARGX) September 2026 Conference Transcript
No reported result — non-financial event
Audio Transcript Slides
Conference
Investor event
2026-09-01
Argenx SE (ARGX) September 2026 Conference Transcript
No reported result — non-financial event
Audio Transcript Slides
Conference
Investor event
2026-06-09
Argenx SE (ARGX) June 2026 Conference Transcript
No reported result — non-financial event
Audio Transcript Slides
Conference
Investor event
2026-06-03
Argenx SE (ARGX) June 2026 Conference Transcript
No reported result — non-financial event
Audio Transcript Slides
Earnings call
FY25 · Q4
2025-12-31
Argenx SE (ARGX) Q4 2025 Earnings Call Transcript
Confident tone VYVGART franchise growth and patient reach MG label expansion (seronegative and ocular) CIDP momentum and label update
Results not yet reported
Audio Transcript Slides 8-K10-K
Earnings call
FY25 · Q3
2025-09-30
Argenx SE (ARGX) Q3 2025 Earnings Call Transcript
Confident tone VYVGART commercial momentum Upcoming 2026 registrational readouts Pipeline expansion and Phase III assets
Results not yet reported
Audio Transcript Slides 8-K10-Q
Earnings call
FY25 · Q2
2025-06-30
Argenx SE (ARGX) Q2 2025 Earnings Call Transcript
Confident tone VYVGART commercial performance CIDP launch progress Indication breadth - myositis, Sjogren's, TED
Results not yet reported
Audio Transcript Slides 8-K10-Q
Earnings call
FY25 · Q1
2025-03-31
Argenx SE (ARGX) Q1 2025 Earnings Call Transcript
Results not yet reported
Audio Transcript Slides 8-K10-Q
Earnings call
FY24 · Q4
2024-12-31
Argenx SE (ARGX) Q4 2024 Earnings Call Transcript
Confident tone VYVGART commercial momentum and launch execution Pipeline expansion and innovation engine Empasiprubart (C2 inhibitor) registrational strategy
Results not yet reported
Audio Transcript Slides 8-K10-K
Earnings call
FY24 · Q3
2024-09-30
Argenx SE (ARGX) Q3 2024 Earnings Call Transcript
Confident tone CIDP launch (VYVGART Hytrulo) VYVGART commercial momentum (gMG) Pipeline and pipeline expansion
Results not yet reported
Audio Transcript Slides 8-K10-Q
Earnings call
FY24 · Q2
2024-06-30
Argenx SE (ARGX) Q2 2024 Earnings Call Transcript
Confident tone CIDP launch Vision 2030 and long-term growth ambitions Clinical trial execution and inherent risks
Results not yet reported
Audio Transcript Slides 8-K10-Q
Earnings call
FY24 · Q1
2024-03-31
Argenx SE (ARGX) Q1 2024 Earnings Call Transcript
Confident tone VYVGART commercial growth Pre-filled syringe and label expansion Clinical pipeline expansion
Results not yet reported
Audio Transcript Slides 8-K10-Q
Earnings call
FY23 · Q4
2023-12-31
Argenx SE (ARGX) Q4 2023 Earnings Call Transcript
Results not yet reported
Audio Transcript Slides 8-K10-K
Earnings call
FY23 · Q3
2023-09-30
Argenx SE (ARGX) Q3 2023 Earnings Call Transcript
Results not yet reported
Audio Transcript Slides 8-K10-Q
Earnings call
FY23 · Q2
2023-06-30
Argenx SE (ARGX) Q2 2023 Earnings Call Transcript
Results not yet reported
Audio Transcript Slides 8-K10-Q
Earnings call
FY23 · Q1
2023-03-31
Argenx SE (ARGX) Q1 2023 Earnings Call Transcript
Results not yet reported
Audio Transcript Slides 8-K10-Q
Earnings call
FY22 · Q4
2022-12-31
Argenx SE (ARGX) Q4 2022 Earnings Call Transcript
Results not yet reported
Audio Transcript Slides 8-K10-K
Earnings call
FY22 · Q2
2022-06-30
Argenx SE (ARGX) Q2 2022 Earnings Call Transcript
Revenue
$96.00M
Audio Transcript Slides 8-K10-Q
Earnings call
FY22 · Q1
2022-03-31
Argenx SE (ARGX) Q1 2022 Earnings Call Transcript
Results not yet reported
Audio Transcript Slides 8-K10-Q
Earnings call
FY21 · Q4
2021-12-31
Argenx SE (ARGX) Q4 2021 Earnings Call Transcript
Results not yet reported
Audio Transcript Slides 8-K10-K
Earnings call
FY21 · Q3
2021-09-30
Argenx SE (ARGX) Q3 2021 Earnings Call Transcript
Results not yet reported
Audio Transcript Slides 8-K10-Q
Earnings call
FY21 · Q2
2021-06-30
Argenx SE (ARGX) Q2 2021 Earnings Call Transcript
Results not yet reported
Audio Transcript Slides 8-K10-Q
Earnings call
FY21 · Q1
2021-03-31
Argenx SE (ARGX) Q1 2021 Earnings Call Transcript
Results not yet reported
Audio Transcript Slides 8-K10-Q
Earnings call
FY20 · Q4
2020-12-31
Argenx SE (ARGX) Q4 2020 Earnings Call Transcript
Results not yet reported
Audio Transcript Slides 8-K10-K
Earnings call
FY20 · Q2
2020-06-30
Argenx SE (ARGX) Q2 2020 Earnings Call Transcript
Results not yet reported
Audio Transcript Slides 8-K10-Q
Earnings call
FY20 · Q1
2020-03-31
Argenx SE (ARGX) Q1 2020 Earnings Call Transcript
Results not yet reported
Audio Transcript Slides 8-K10-Q
Showing 1–27 of 27 earnings calls
Key facts CIK 1697862 CUSIP 04016X101 13F (30d) 11 filings 11 filers Visit website Investor relations